The clinical utility of a low glycemic index (LGI) diet for appetite and food intake control is controversial. Complicating the issue are psychological and behavioral influences related to eating. Objective: The aim of this study was to investigate the satiety and glycemic response to high GI (HGI) and LGI meals in overweight restrained (R, n ¼ 12) and unrestrained (UR, n ¼ 10) women. Design and measurements: In a randomized crossover study, subjective satiety, cholecystokinin (CCK), glucose, insulin, triacylglyceride (TG) and free fatty acids (FFAs) were measured at defined intervals for 8 h after the participants consumed HGI or LGI test meals. Test meals were matched for energy, energy density, macronutrient content and available carbohydrate, but differed by carbohydrate source; refined grain versus whole grain, respectively. Results: The HGI meal resulted in greater satiety overall, suppressing hunger, desire to eat and prospective consumption compared with the LGI (Po0.01) meal. Plasma CCK was significantly elevated after the HGI meal compared with the LGI meal (Po0.001). Plasma glucose, insulin and TG were higher and FFAs were lower after the HGI meal compared with the LGI meal (Po0001). Dietary restraint did not significantly influence CCK (P ¼ 0.14) or subjective satiety (P40.4); however, an interaction of restraint and disinhibition on CCK was apparent. CCK was blunted in R participants with higher disinhibition scores than UR or R participants with lower disinhibition scores (Po0.05). Conclusions: A LGI diet may not be suitable for optimal satiety and appetite control in overweight women. The relationship between cognitive influences of eating and biobehavioral outcomes requires further investigation.
Introduction
The glycemic index (GI) is suggested as a useful strategy for achieving and maintaining a healthy body weight. 1, 2 However, variability among dietary components, energy status and experimental design challenge scientific agreement as to the effectiveness of GI. GI of a food is defined as the incremental area under the plasma glucose response curve of a 50 g carbohydrate portion of a test food expressed as a percentage of the response to the same amount of carbohydrate from a reference food: usually white bread or glucose solution. 3 Carbohydrate-rich foods raise blood glucose concentrations more so than fat-or protein-rich foods, and hence, recent dietary trends promote higher levels of protein intake, touting the threat of carbohydrates to metabolic control and energy balance. The claimed benefits of low GI (LGI) foods and diets include greater control of appetite, body weight, blood glucose, insulin and cholesterol, resulting in reduced risk for type 2 diabetes mellitus, cardiovascular disease and prevention and management of obesity. [4] [5] [6] [7] [8] Long-term studies, however, have reported no difference in weight loss between
LGI and high GI (HGI) diets. [9] [10] [11] [12] Benefits in the maintenance of weight loss also seem questionable. In an 18-month study, comparing LGI and HGI diets, higher rates of body weight regain were observed on the LGI diet after maximal weight loss compared with the HGI diet group (P ¼ 0.11). 10 Evaluation of hunger and other satiety indicators in short-and long-term dietary intervention studies is variable. 10, 13, 14 Even with simple preparations of glucose and fructose with distinct glycemic responses, satiety was greater after the glucose load than fructose load. 15 Inconsistent associations between GI and body mass index have also been reported. 7 Hence, the role of GI diets in managing appetite/satiety and overall body weight remains a debated topic. Many dietary factors influence GI, including food processing, food matrix, nutrient bioavailability and the interaction of nutrients within the meal itself. These same factors also influence the rate and capacity of digestion and absorption. Digestive and absorptive mechanisms are tightly regulated by hormonal responses, such as cholecystokinin (CCK) and insulin. These peripherally derived signals are sensitive to incoming dietary composition and help to orchestrate and direct information between and along the gut-brain axis to allow for optimal use, metabolism and storage of nutrients from the diet. These signals also serve as critical indicators of short-and long-term energy needs. In this way, endocrine responses to food intake are critical for meal-to-meal food intake regulation and overall energy homeostasis.
Both homeostatic and nonhomeostatic systems are involved in food intake. It has been suggested that the rise in obesity may be, at least in part, because of the activation of nonhomeostatic, food reward centers in the brain that override hormonal regulation of food intake. 16, 17 Cognitive dietary restraint is a pattern of attempted weight control characterized by cognitive restriction of food intake that has paradoxically been linked with overeating and/or weight gain. 18 We had reported earlier that the patterns of eating coincident with cognitive dietary restraint suppress the gut hormone response to a test meal intermediate in glycemic load in normal weight men and women. 19 The aim of this study was to investigate the relationship of GI, satiety and biological response patterns of key mediators of short-term food intake in a population of restrained (R) and unrestrained (UR) overweight women. The primary working hypothesis was that the satiety effect of LGI and HGI meals will be determined by the biological response patterns and that women exhibiting high dietary restraint will be less responsive to satiety cues.
Methods
The Human Subjects Research Committee of the University of California, Davis, approved the study. The study was conducted in accordance with the Helsinki Declaration of 1975 as revised in 1983. All participants signed a written informed consent form before any study-related procedures were performed.
Participants
Twenty-five nonsmoking women between 20 and 50 years of age participated in this study after passing the initial health screening consisting of medical history, clinical blood chemistries and blood pressure measurements. All volunteers were overweight with body mass index in the range of 25.0-29.9 kg/m 2 . Volunteers were excluded if they had indications of cardiovascular or metabolic disorders, were pregnant or had been pregnant within 18 months before the study and/ or were taking medications or herbal supplements to manage body weight or control appetite. Volunteers agreed to remain weight stable during the period of the study and refrain from remarkable changes in diet and habitual physical activity level. In general, participants were requested to maintain current dietary and physical activity patterns. Upon entry into the study, the participants completed the Three Factor Eating Questionnaire 20 to characterize the participants on the levels of dietary restraint and disinhibition. Cognitive restraint was based on factor 1 scores of more than 10. Disinhibition was based on factor 2 scores of more than 7.
The study reported here is a component of a larger metabolic study of which portions have been published earlier. 21, 22 The final analysis of this report includes 22 of the original 25 participants enrolled. This is because of a protocol amendment to increase sample volume to accommodate the CCK analysis after the first three participants had been studied. The results of this study are based on the 22 participants enrolled after the amendment.
Study design
The study was a two-arm, two-sequence, randomized crossover design to characterize the satiety response to two breakfast meals defined on the basis of GI: HGI breakfast meal versus LGI breakfast meal. Satiety response was determined by measured changes in subjective satiety (that is, ratings of hunger, fullness, desire to eat and prospective consumption) and plasma CCK from baseline (fasting state) to 8 h post-breakfast consumption. Changes in glucose, insulin, triacylglycerides (TGs) and free fatty acids (FFAs) were also measured. All volunteers participated in both treatment arms, each time during the follicular phase of their menstrual cycle. Each 8-h-study day was preceded by a 3-day diet run-in period consisting of foods (all provided) that corresponded to the breakfast meal to be served on the study 'test' day (day 4).
Diets and test meal
Breakfast test meals and treatment-control run-in diets were created using the computer software ProNutra (Princeton Multimedia Technologies, Princeton, NJ, USA 
Study protocol
On study 'test' days, participants arrived at the laboratory between 0700 and 0800 hours, following an overnight fast. Body weight and height were measured with the participant wearing a surgical scrub outfit of a known weight and no shoes using an electronic scale (Val-Del Scale Co., Rancho Cordova, CA, USA) and stadiometer (Model S100, Aryton Corp, 134 Prior Lake, MN, USA). Body mass index was calculated by using weight and height measures. Body composition was determined by dual-energy X-ray absorptiometry using a whole body scan (Lunar Prodigy, GE Medical Corp., Madison, WI, USA). Analysis was performed using software version 2.05. Following these measurements, a nurse inserted an antecubital indwelling catheter and let the participant rest comfortably and quietly for approximately 30 min. During this time, procedures for calibrating the gas analyzers in the metabolic cart were performed. After the participant had rested for 30 min, they were asked to rate their level of hunger, fullness, desire to eat and prospective consumption on visual analog scales (VAS) administered through a handheld palm pilot, the Palm Zire 21 (Sunnyvale, CA, USA). Thereafter, a measurement of resting energy expenditure was taken by collecting expired gases for 20 min to determine oxygen consumption (l min
À1
, VO 2 ) and carbon dioxide production (l min À1 , 145 VCO 2 ). Following this measurement, the first fasting blood sample was obtained and a second rating of subjective satiety rating was collected. After a 20-min rest, a second 20-min gas collection was carried out. Following this sequence of gas collectionblood draw-gas collection, the participant rated their state of hunger and satiety and was then given the scheduled breakfast test meal. Participants consumed the meal within 15 min, and over the subsequent 8 h, respiratory gases were collected for 20 min intervals, subjective ratings of satiety were collected and the blood samples were drawn. Time points for rating satiety followed by the blood sampling for CCK analysis were time (T)30, T60, T90, T120, T150, T210, T270, T360 and T480 min following the breakfast test meal, and the participant rested quietly throughout this 8-h time period in a semi-reclined position.
Analyses
Subjective satiety was assessed using VAS methodology applied to and administered through a Palm Zire 21 (Sunnyvale). Participants rated their levels of hunger, fullness, desire to eat, prospective consumption, nausea, thirst and satisfaction of preload on-line scales shown on the PDA screen. Questions such as 'how hungry do you feel right now?' or 'how strong is your desire to eat right now?' preceded a line anchored by opposing phrases 'not at all' and 'extremely'. Other anchors consisted of the phrases 'none' and 'extremely large amount' to access prospective consumption. Use and value of these scales for assessing motivation to eat and food preference have been reported earlier. 19 Blood samples were collected in EDTA coated vacutainer tubes (for CCK and TG analyses) and in sodium fluoride/ potassium oxalate vacutainer tubes (for glucose analysis), immediately cooled in ice, and plasma was obtained by centrifugation (Centra CL3R centrifuge, International Equipment Co., Chattanooga, TN, USA) at 1300 g for 10 min at 23 1C. Three 1 ml aliquots of plasma þ aprotinin (protease inhibitor) were frozen at À80 1C for the determination of CCK concentrations by radioimmunoassay. Other aliquots (B1 ml) of plasma were stored in microcentrifuge tubes and frozen at -80 1C for subsequent analysis of glucose and TG. Blood samples were also drawn into vacutainers with no additives, allowed to sit at room temperature for B20 min to allow for clotting, and centrifuged at 1300 g for 10 min at 23 1C. Aliquots (B1 ml) of serum were transferred to microcentrifuge tubes and frozen at À80 1C for analysis of insulin and FFAs concentrations. GI meal and satiety, disinhibition and CCK BM Burton-Freeman and NL Keim Plasma CCK was measured by commercial RIA kit purchased from Immuno-Biological Laboratories Inc. (Minneapolis, MN, USA kit number RB 302). This kit uses a highly specific and selective antibody for the bioactive CCK in plasma and has been used earlier in our lab. 19 Plasma glucose was determined through an enzymatic assay (Roche Diagnostics Corp., Indianapolis, IN, USA) using a Hitachi Automatic Analyzer (Boehringer Manheim Corp., Indianapolis, IN, USA). Insulin was determined through a solid-phase, two-site, chemiluminescent enzyme-labeled immunometric assay using an Immulite analyzer (Diagnostic Products Corp., Los Angeles, CA, USA). TGs and FFAs were analyzed using enzymatic assays (Roche Diagnostics Corp.,and Wako Chemicals USA Inc., Richmond VA, USA, respectively). These assays were adapted for the Hitachi Automatic Analyzer.
Laboratory analysis was performed in batches according to the Standardization Program of the US Centers for Disease Control and Prevention and the National Heart Lung and Blood Institute.
Statistical analysis
Data were analyzed by repeated measures analysis of variance using PC-SAS (version 8.2; SAS Institute Inc., Cary, NC, USA), GLM and MIXED procedure with breakfast meal and time as main factors, and participant as the blocking variable. Data analyzed from the VAS were first converted to increments above baseline to account for relative baseline variability among participants.
Substrate metabolites not conforming to expected distributional assumptions were log transformed and noted accordingly. Significant differences among treatment means were analyzed by pairwise t-test and Tukey's honestly significant test for appropriate comparisons. The level used to determine statistical significance was Po0.05.
Results

Participant characteristics
Twenty-two women participated in the study. Mean ( ± s.d.) age (years), body mass index (kg/m 2 ), percent body fat were 31 ± 8 years, 27 ± 1 and 39 ± 3%, respectively. All participants maintained their body weight within 1.0 kg throughout the study.
Twelve women met criteria for cognitive restraint (scores 410 on the Three Factor Eating questionnaire (factor 1); 20 mean±s.d., 13.5±2.7) and 10 participants were characterized as UR (mean score, 6.5±2.3). Mean scores for disinhibition (factor 2) and hunger (factor 3) were 7.6 ± 3.0 and 4.6 ± 2.8, respectively.
Subjective satiety (VAS)
In overweight women, the HGI meal suppressed hunger by approximately 20% more than the LGI meal (Figure 1a , P ¼ 0.009). Similarly, the HGI meal induced a greater suppression on desire to eat and prospective consumption compared with the LGI meal (26 and 36% more respectively, P ¼ 0.007 and P ¼ 0.001, Figures 1b and c) . There was no difference in the ratings of sensation of fullness (P40.2, Figure 1d ) between HGI and LGI meals in participants. Overweight women given a HGI meal were more satiated than those given an LGI meal. GI meal and satiety, disinhibition and CCK BM Burton-Freeman and NL Keim by the 90 min blood draw, a significant separation in concentration time curves was apparent, favoring higher CCK with the HGI meal. By 4.5 h, concentrations of CCK in response to the LGI and HGI meals were not different. Consistent with the pattern of response, the area under the CCK response curve (AUC) was significantly greater after consumption of the HGI meal compared with the LGI meal (Po0.05) in these overweight women. In addition to the elevated CCK, the HGI meal also produced higher concentrations of glucose, insulin, and TGs and lower FFAs than the LGI meal (Po0.0001, Figures 3-6 ). Glucose and insulin concentrations rose immediately with consumption of meals, and the meal-associated concentration differences were apparent at the 30 min blood sample (glucose: 110 ± 2.7 versus 103 ± 2.6 mg per 100 ml, Po0.05; insulin: 102 ± 7.1 versus 60 ± 7.3 pmol l À1 , respectively Po0.05). By 4.5 h, both glucose and insulin concentrations in response to the meals were no longer different (Figures 3  and 4) . The plasma TG response to the LGI meal seemed delayed compared with the HGI meal ( Figure 5 ). For the first 150 min, plasma TG concentrations were significantly lower after the LGI meal compared with the HGI meal (Po0.05). Thereafter, concentrations were not different from 2.5 to 8 h. Serum FFAs were significantly lower after the HGI meal (least square mean as estimate of response 0.286 ± 0.010 and 0.340 ± 0.009 mmol l À1 for HGI and LGI, respectively, Po0.001 (76.9±2.7 and 91.5 ± 2.4 mg l À1 )). The time concentration curve is shown in Figure 6 illustrating the meal by time interaction (Po0.0001).
Biobehavioral interactions
Dietary restraint did not influence plasma CCK concentrations in response to meals; however, among R participants, those with higher disinhibition scores (scores of 47) had a blunted CCK response to both meals (RFhigh disinhibition, CCK pM ¼ 1.6 ± 0.6, RFlow disinhibition, CCK pM ¼ 3.2 ± 0.5, UR CCK pM ¼ 3.1 ± 0.4; Po0.05). The time concentration curve of this response is shown in Figure 2b . Disinhibition alone was not significant (P40.4). Interaction between endocrine responses to test meals and cognitive dietary restraint did not influence perceived satiety as measured by VAS.
Discussion
The primary objective of this study was to investigate the relationship of GI, satiety and biological response patterns of key mediators of short-term food intake in a population of R and UR overweight women. We have shown earlier that dietary restraint blunts the CCK response to meals in healthy weight men and women. We were interested in extending these findings using GI distinct meals in an overweight female population characterized by R or UR eating behavior and further testing the relationship with subjective satiety. Although cognitive dietary restraint as a main factor did not influence satiety outcomes in this study of all women, disinhibition among R eaters surfaced as a potential factor in the CCK response to meals. Overweight women with high disinhibition scores within the construct of dietary restraint had a lower overall CCK response to the test meals than either the R participants with low disinhibition scores or the participants who scored as UR. To the best of our knowledge, this is the first report of an interaction of dietary restraint and disinhibition on endocrine responses, namely CCK, to food intake. Dietary restraint describes the tendency to control consciously food intake to prevent weight gain or to achieve weight loss, whereas disinhibition refers to the breakdown of this cognitive control. Overeating, disordered eating, particularly binge eating disorder and bulimia nervosa, weight gain and weight regain after weight loss is associated with the higher disinhibition scores both in clinical and nonclinical individuals. [23] [24] [25] [26] [27] Moreover, it seems that the severity of eating pathology is associated with high disinhibition scores together with high restraint scores, suggesting that the conflict of high disinhibition in the presence of restraint is important in the dysregulation of eating. 27 A biological basis in support of these findings has only been vague with conflicting reports on leptin and ghrelin, [28] [29] [30] and there is no information on postprandial satiety signaling. The blunted CCK response that we report here is of interest in light of data indicating that postprandial CCK is blunted in bulimia nervosa and restored with successful treatment. Our data provide a biological basis for progression and persistence of disordered eating, and may serve to confirm successful treatment therapy targeting reductions in disinhibition, and possibly reduce relapse, especially since changes in the Three Factor Eating Questionnaire scoring are minimal during recovery. These findings warrant replication as well as future research in identifying patterns of released satiety signals corresponding to food intake patterns associated with behavioral and psychological correlates that promote unfavorable changes in food intake and body weight. In addition to our findings of CCK, disinhibition and restraint, we also found that in overweight women, a HGI breakfast meal provided greater overall satiety than a LGI breakfast meal. These data are in contrast to the current dogma of eating LGI meals, where LGI is expected to be superior to HGI eating in managing appetite and body weight. Although the LGI meal provided for lower postprandial concentrations of glucose, insulin and TGs, consistent with the claims of LGI, 31, 32 it did not induce greater satiety. Rather, the higher ratings of hunger, desire to eat and prospective consumption after the LGI meal were associated with a lower CCK secretory response compared with the HGI meal. One possible explanation is the proposed relationship between circulating postprandial metabolic factors and CCK, in which higher circulating FFAs results in lower CCK concentrations. 33 In this study, the LGI meal was associated with higher circulating FFAs; however, the magnitude of difference among meals was not as robust as one might expect to explain the difference in CCK. Nonetheless, the concept is modestly supported in this study and deserves follow up to better understand the metabolic influence on CCK release in response to meals. In humans, fat is a potent stimulator of CCK followed by protein and then carbohydrate, all of which were matched in the two treatment meals. However, dietary fiber was not matched. The LGI meal contained 10-fold more fiber than the HGI meal. Directly, dietary fiber does not seem to stimulate CCK release. However, its action in the gut, dependent on the physical-chemical properties of the ingested fiber with coexisting nutrients can modify CCK release. 34, 35 The fiber used in the LGI meal was predominantly insoluble (for example, cellulose). Insoluble sources of dietary fiber provide bulk to the diet and decrease transit time through the gastrointestinal tract. The stimulation of CCK release by nutrients is maximal in the duodenum diminishing with passage of nutrients through the jejunum as CCK-secreting I cells become scarce. Hence, factors hastening transit, such as insoluble fiber, may result in a reduced endocrine response from the upper small intestine including CCK. We suspect that this is a major reason for the reduced CCK response in the LGI meal. As women seem to be sensitive to intestinal phase satiety events, perhaps more so than gastric phase events (that is, distension) as we have seen in men, 36 the reduced CCK in the LGI meal translated to reduced sensations of satiety. No differences in fullness were reported among these women further supporting the importance of intestinal satiety for women. These data have important implications for devising meal plans for achieving and maintaining a healthy body weight. Individuals who are overweight and obese comprise the target population for weight-reducing diets. Long-term compliance and success of these diets depends greatly on managing appetite and hunger. Hence, dietary prescriptions focused on LGI methodology, at least with the use of insoluble fibers, may not be well suited for overweight women requiring strong satiety signaling.
